Itchaki G, Brown JR. Experience with ibrutinib for first-line use in patients with chronic lymphocytic leukemia. Ther Adv Hematol. 2018;9(1):3–19.
Article CAS PubMed Google Scholar
Ishizaka Y, Itoh F, Tahira T, Ikeda I, Sugimura T, Tucker J, et al. Human ret proto-oncogene mapped to chromosome 10q11. 2. Oncogene. 1989;4(12):1519–21.
Arighi E, Borrello MG, Sariola H. RET tyrosine kinase signaling in development and cancer. Cytokine Growth Factor Rev. 2005;16(4–5):441–67.
Article CAS PubMed Google Scholar
Barletta JA, Nosé V, Sadow PM. Genomics and epigenomics of medullary thyroid carcinoma: from sporadic disease to familial manifestations. Endocr Pathol. 2021:1–9.
Khan MS, Qadri Q, Makhdoomi MJ, Wani MA, Malik AA, Niyaz M, et al. RET/PTC gene rearrangements in thyroid carcinogenesis: assessment and clinico-pathological correlations. Pathol Oncol Res. 2020;26(1):507–13.
Article CAS PubMed Google Scholar
Mayr B, Pötter E, Goretzki P, Rüschoff J, Dietmaier W, Hoang-Vu C, et al. Expression of RET/PTC1,-2,-3,-∆3 and-4 in german papillary thyroid carcinoma. Br J Cancer. 1998;77(6):903–6.
Article CAS PubMed PubMed Central Google Scholar
Wajjwalku W, Nakamura S, Hasegawa Y, Miyazaki K, Satoh Y, Funahashi H, et al. Low frequency of rearrangements of the ret and trk proto-oncogenes in japanese thyroid papillary carcinomas. Jpn J Cancer Res. 1992;83(7):671–5.
Article CAS PubMed PubMed Central Google Scholar
Bounacer A, Wicker R, Schlumberger M, Sarasin A, Suarez H. Oncogenic rearrangements of the ret proto-oncogene in thyroid tumors induced after exposure to ionizing radiation. Biochimie. 1997;79(9–10):619–23.
Article CAS PubMed Google Scholar
Smida J, Salassidis K, Hieber L, Zitzelsberger H, Kellerer AM, Demidchik EP, et al. Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus. Int J Cancer. 1999;80(1):32–8.
Article CAS PubMed Google Scholar
Belli C, Penault-Llorca F, Ladanyi M, Normanno N, Scoazec J-Y, Lacroix L et al. ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research. Ann Oncol. 2021.
Drilon A, Hu ZI, Lai GG, Tan DS. Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes. Nat Reviews Clin Oncol. 2018;15(3):151.
Subbiah V, Cote GJ. Advances in targeting RET-dependent cancers. Cancer Discov. 2020;10(4):498–505.
Article CAS PubMed PubMed Central Google Scholar
Markham A. Selpercatinib: first approval. Drugs. 2020;80(11):1119–24.
Article CAS PubMed PubMed Central Google Scholar
Della Corte C, Morgillo F. Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA. ESMO open. 2021;6(1).
US Food and Drug Administration. FDA approves pralsetinib for RET-altered thyroid cancers 2020 [updated 12/01/2020. Available from: https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-pralsetinib-ret-altered-thyroid-cancers#:~:text=On%20December%201%2C%202020%2C%20the,fusion%2Dpositive%20thyroid%20cancer%20who.
Moore DE Jr. Needs assessment in the new health care environment: combining discrepancy analysis and outcomes to create more effective CME. J Continuing Educ Health Professions. 1998;18(3):133–41.
Creswell JW, Klassen AC, Plano Clark VL, Smith KC. Best practices for mixed methods research in the health sciences. Volume 2013. Bethesda (Maryland): National Institutes of Health; 2011. pp. 541–5.
Atkins L, Francis J, Islam R, O’Connor D, Patey A, Ivers N, et al. A guide to using the theoretical domains Framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12(1):77.
Article PubMed PubMed Central Google Scholar
West R, Michie S. A brief introduction to the COM-B model of behaviour and the PRIME theory of motivation [v1]. Qeios. 2020.
Turner SF, Cardinal LB, Burton RM. Research design for mixed methods: a triangulation-based framework and roadmap. Organizational Res Methods. 2017;20(2):243–67.
ICC/ESOMAR. ICC/ESOMAR international code on market, opinion and social research and data analytics 2016 [Available from: https://www.esomar.org/what-we-do/code-guidelines].
Etikan I, Musa SA, Alkassim RS. Comparison of convenience sampling and purposive sampling. Am J theoretical Appl Stat. 2016;5(1):1–4.
Kallio H, Pietilä AM, Johnson M, Kangasniemi M. Systematic methodological review: developing a framework for a qualitative semi-structured interview guide. J Adv Nurs. 2016;72(12):2954–65.
Bearman M. Eliciting rich data: a practical approach to writing semi-structured interview schedules. Focus on Health Professional Education: A Multi-disciplinary Journal. 2019;20(3):1–11.
Simms LJ, Zelazny K, Williams TF, Bernstein L. Does the number of response options matter? Psychometric perspectives using personality questionnaire data. Psychol Assess. 2019;31(4):557.
Chyung SY, Roberts K, Swanson I, Hankinson A. Evidence-based survey design: the use of a midpoint on the Likert scale. Perform Improv. 2017;56(10):15–23.
Considine J, Botti M, Thomas S. Design, format, validity and reliability of multiple choice questions for use in nursing research and education. Collegian. 2005;12(1):19–24.
Wilson C. Interview techniques for UX practitioners: a user-centered design method. Morgan Kaufmann Publishers; 2013. [Available from: https://doi.org/10.1016/C2012-0-06209-6]
O’Flaherty B, Whalley J. Qualitative analysis software applied to is research-Developing a coding strategy. ECIS 2004 Proceedings. 2004:123.
Zamawe FC. The implication of using NVivo software in qualitative data analysis: evidence-based reflections. Malawi Med J. 2015;27(1):13–5.
Article CAS PubMed PubMed Central Google Scholar
Roberts K, Dowell A, Nie J-B. Attempting rigour and replicability in thematic analysis of qualitative research data; a case study of codebook development. BMC Med Res Methodol. 2019;19(1):1–8.
McKight PE, Najab J. Kruskal-wallis test. The corsini encyclopedia of psychology. 2010:1-.
O’Cathain A, Murphy E, Nicholl J. Three techniques for integrating data in mixed methods studies. BMJ. 2010;341.
National Comprehensive Cancer Network. Thyroid Carcinoma Version 3.2021: National Comprensive Cancer Network (NCCN); 2021 [cited 2021 October 15]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf.
James BC, Aschebrook-Kilfoy B, White MG, Applewhite MK, Kaplan SP, Angelos P, et al. Quality of life in thyroid cancer—assessment of physician perceptions. J Surg Res. 2018;226:94–9.
Salvatore D, Santoro M, Schlumberger M. The importance of the RET gene in thyroid cancer and therapeutic implications. Nat Reviews Endocrinol. 2021;17(5):296–306.
Shojaie D, Hoffman AS, Amaku R, Cabanillas ME, Sosa JA, Waguespack SG, et al. Decision making when Cancer becomes chronic: needs Assessment for a web-based medullary thyroid carcinoma patient decision aid. JMIR formative research. 2021;5(7):e27484.
Article PubMed PubMed Central Google Scholar
Díez JJ, Galofré JC. Thyroid cancer patients satisfaction at the management outcome: an analysis of the results of a nationwide survey in 485 subjects. BMC Health Serv Res. 2021;21(1):1–9.
Michie S, Atkins L, West R. The behaviour change wheel. A guide to designing interventions 1st ed Great Britain: Silverback Publishing. 2014:1003-10.
Cowdell F, Dyson J. How is the theoretical domains framework applied to developing health behaviour interventions? A systematic search and narrative synthesis. BMC Public Health. 2019;19(1):1–10.
Roy M, Chen H, Sippel RS. Current understanding and management of medullary thyroid cancer. Oncologist. 2013;18(10):1093.
Article PubMed PubMed Central Google Scholar
Gautschi O, Milia J, Filleron T, Wolf J, Carbone DP, Owen D, et al. Targeting RET in patients with RET-rearranged lung cancers: results from the global, multicenter RET registry. J Clin Oncol. 2017;35(13):1403.
Article CAS PubMed PubMed Central Google Scholar
Tamborero D, Dienstmann R, Rachid MH, Boekel J, Baird R, Braña I, et al. Support systems to guide clinical decision-making in precision oncology: the Cancer Core Europe Molecular Tumor Board Portal. Nat Med. 2020;26(7):992–4.
Article CAS PubMed Google Scholar
Fleisher L, Ruggieri DG, Miller SM, Manne S, Albrecht T, Buzaglo J, et al. Application of best practice approaches for designing decision support tools: the preparatory education about clinical trials (PRE-ACT) study. Patient Educ Couns. 2014;96(1):63–71.
Article PubMed PubMed Central Google Scholar
McLean SF. Case-based learning and its application in medical and health-care fields: a review of worldwide literature. J Med Educ Curric Dev. 2016;3:JMECD.S20377.
Article PubMed PubMed Central Google Scholar
Liu L, Li M, Zheng Q, Jiang H. The Effects of Case-Based teaching in nursing Skill Education: cases do Matter. INQUIRY: The Journal of Health Care Organization Provision and Financing. 2020;57:0046958020964421.
O’cathain A, Murphy E, Nicholl J. The quality of mixed methods studies in health services research. J Health Serv Res Policy. 2008;13(2):92–8.
Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015;350.
Moscoso SC, Chaves SS, Vidal MP, Argilaga MTA. Reporting a program evaluation: needs, program plan, intervention, and decisions. Int J Clin Health Psychol. 2013;13(1):58–66.
Dasch B, Kalies H, Feddersen B, Ruderer C, Hiddemann W, Bausewein C. Care of cancer patients at the end of life in a german university hospital: a retrospective observational study from 2014. PLoS ONE. 2017;12(4):e0175124.
Comments (0)